IL135014A0 - A pharmaceutical composition for treating stress comprising pretreated blood - Google Patents

A pharmaceutical composition for treating stress comprising pretreated blood

Info

Publication number
IL135014A0
IL135014A0 IL13501498A IL13501498A IL135014A0 IL 135014 A0 IL135014 A0 IL 135014A0 IL 13501498 A IL13501498 A IL 13501498A IL 13501498 A IL13501498 A IL 13501498A IL 135014 A0 IL135014 A0 IL 135014A0
Authority
IL
Israel
Prior art keywords
radiation
ozone
mild heating
blood
oxygen gas
Prior art date
Application number
IL13501498A
Other languages
English (en)
Original Assignee
Vasogen Ireland Ltd
Ct De Rech Du Ct Hospitalier D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Vasogen Ireland Ltd, Ct De Rech Du Ct Hospitalier D filed Critical Vasogen Ireland Ltd
Publication of IL135014A0 publication Critical patent/IL135014A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Heads (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
IL13501498A 1997-09-12 1998-09-11 A pharmaceutical composition for treating stress comprising pretreated blood IL135014A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US5917297P 1997-09-17 1997-09-17
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses
PCT/CA1998/000869 WO1999013890A1 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress

Publications (1)

Publication Number Publication Date
IL135014A0 true IL135014A0 (en) 2001-05-20

Family

ID=27427399

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13501498A IL135014A0 (en) 1997-09-12 1998-09-11 A pharmaceutical composition for treating stress comprising pretreated blood
IL13501898A IL135018A0 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress
IL135018A IL135018A (en) 1997-09-12 2000-03-12 Use of stressed blood in a medicament for treating stress and preconditioning against stress

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL13501898A IL135018A0 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress
IL135018A IL135018A (en) 1997-09-12 2000-03-12 Use of stressed blood in a medicament for treating stress and preconditioning against stress

Country Status (12)

Country Link
EP (1) EP1011696B1 (da)
JP (1) JP4141636B2 (da)
AT (1) ATE253922T1 (da)
AU (1) AU741181B2 (da)
DE (1) DE69819749T2 (da)
DK (1) DK1011696T3 (da)
EA (1) EA003232B1 (da)
ES (1) ES2210814T3 (da)
IL (3) IL135014A0 (da)
NZ (1) NZ503770A (da)
PT (1) PT1011696E (da)
WO (1) WO1999013890A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534473A (ja) * 1999-01-12 2002-10-15 パヴェル ハメット， 細胞死に対する予備条件付け
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
CA2271190A1 (en) * 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
ATE263540T1 (de) * 1999-09-16 2004-04-15 Vasogen Ireland Ltd Vorrichtung zum beeinflussen des blutes eines säugetieres
WO2001022976A2 (en) * 1999-09-24 2001-04-05 Vasogen Ireland Limited Combination of a statin and ex-vivo treated blood for treating artheroclerosis
CA2296997A1 (en) 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
WO2003024422A1 (en) * 2001-09-18 2003-03-27 Vasogen Ireland Limited Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3989949B2 (ja) * 1992-02-07 2007-10-10 バソジェン アイルランド リミテッド 血中の酸化窒素濃度を増加させる方法
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
ATE246929T1 (de) * 1995-05-05 2003-08-15 Vasogen Ireland Ltd Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
DK1011696T3 (da) 2004-03-15
IL135018A0 (en) 2001-05-20
HK1031322A1 (en) 2001-06-15
JP4141636B2 (ja) 2008-08-27
EP1011696A1 (en) 2000-06-28
ES2210814T3 (es) 2004-07-01
PT1011696E (pt) 2004-03-31
NZ503770A (en) 2002-10-25
IL135018A (en) 2006-06-11
DE69819749T2 (de) 2004-09-30
WO1999013890A1 (en) 1999-03-25
AU741181B2 (en) 2001-11-22
AU9148098A (en) 1999-04-05
EP1011696B1 (en) 2003-11-12
JP2001516723A (ja) 2001-10-02
DE69819749D1 (de) 2003-12-18
ATE253922T1 (de) 2003-11-15
EA003232B1 (ru) 2003-02-27
EA200000312A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
UA32429C2 (uk) Засіб для лікування нетримання сечі
UY24805A1 (es) Peptidos y compuestos que se enlazan al receptor de la trombopoyetina
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
ATE273025T1 (de) Dha-pharmazeutisches produkt konjugate
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
BG101392A (en) Method of treating diabetes mellitus using kgf
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
AR005940A1 (es) Composicion cosmetica de fijacion y brillo en aerosol, y procedimiento
DE3788231D1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
ES2157833A1 (es) Procedimiento para el tratamiento de suelas de zapatos mediante radiacion ultravioleta combinada con ozono.
IL135014A0 (en) A pharmaceutical composition for treating stress comprising pretreated blood
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
AU2566295A (en) Photodynamic conjugates with biocidal properties
EP0728219A4 (en) WET TREATMENT OF LEATHER AND FUR
MY120530A (en) Combination preparation for use in dementia
ES2159627T3 (es) Formulacion energetica.
ES2173464T3 (es) Preparacion de clorinas y bacterioclorinas con contenido en polieter.
PL336163A1 (en) Application of oligomeric cartilage intercellular substance protein in treating rheumatologic arthritis
BR9709989A (pt) Processos para tratamento de uma doenca de planta, para preparacão de uma substância ou composicão para tratamento de doenca de planta e para fertilizacão de uma planta, para fertilizacao de uma planta, substâncias ou composicões para tratamento de uma doenca de planta e para fertilizacão de uma planta, e, uso das mesmas.
FR2891140B1 (fr) Procede de traitement des fibres keratiniques par application d'un melange eau liquide/vapeur d'eau
DE69228869D1 (de) Stabilisierte antikörperfragmente
AU1275400A (en) Method and apparatus for treating contaminated waste